These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17991386)

  • 1. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.
    Meijer A; Lackenby A; Hay A; Zambon M
    Euro Surveill; 2007 Apr; 12(4):E3-4. PubMed ID: 17991386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the editor: Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.
    Ciancio BC; Nicoll A
    Euro Surveill; 2007 Jun; 12(6):E070628.4; author reply E070628.5. PubMed ID: 17868571
    [No Abstract]   [Full Text] [Related]  

  • 4. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
    Hurt AC; Holien JK; Parker MW; Barr IG
    Drugs; 2009; 69(18):2523-31. PubMed ID: 19943705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.
    Pozo F; Lina B; Andrade HR; Enouf V; Kossyvakis A; Broberg E; Daniels R; Lackenby A; Meijer A;
    J Clin Virol; 2013 May; 57(1):5-12. PubMed ID: 23375738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.
    Nicoll A; Ammon A; Amato Gauci A; Ciancio B; Zucs P; Devaux I; Plata F; Mazick A; Mølbak K; Asikainen T; Kramarz P
    Public Health; 2010 Jan; 124(1):14-23. PubMed ID: 20141821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of optimal antiviral stockpile for a novel influenza pandemic.
    Kim S; Bin Seo Y; Lee J; Kim YS; Jung E
    J Infect Public Health; 2022 Jul; 15(7):720-725. PubMed ID: 35667304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective.
    Carrasco LR; Lee VJ; Chen MI; Matchar DB; Thompson JP; Cook AR
    J R Soc Interface; 2011 Sep; 8(62):1307-13. PubMed ID: 21296791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemics, antiviral stockpiles and biosecurity in Australia: what about the generic option?
    Lokuge B; Drahos P; Neville W
    Med J Aust; 2006 Jan; 184(1):16-20. PubMed ID: 16398625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
    Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
    Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirals in the management of an influenza pandemic.
    Harrod ME; Emery S; Dwyer DE
    Med J Aust; 2006 Nov; 185(S10):S58-61. PubMed ID: 17115954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the community network of reference laboratories for human influenza in Europe.
    Meijer A; Valette M; Manuguerra JC; Pérez-Breña P; Paget J; Brown C; van der Velden K;
    J Clin Virol; 2005 Oct; 34(2):87-96. PubMed ID: 16157259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.
    Okomo-Adhiambo M; Mishin VP; Sleeman K; Saguar E; Guevara H; Reisdorf E; Griesser RH; Spackman KJ; Mendenhall M; Carlos MP; Healey B; St George K; Laplante J; Aden T; Chester S; Xu X; Gubareva LV
    Antiviral Res; 2016 Apr; 128():28-35. PubMed ID: 26808479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe.
    Meijer A; Brown C; Hungnes O; Schweiger B; Valette M; van der Werf S; Zambon M;
    Vaccine; 2006 Nov; 24(44-46):6717-23. PubMed ID: 16782242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of influenza in the EISS European network member countries from October 2000 to April 2001.
    Manuguerra JC; Mosnier A; Paget WJ;
    Euro Surveill; 2001 Sep; 6(9):127-35. PubMed ID: 11891380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China.
    Huang W; Cheng Y; Li X; Tan M; Wei H; Zhao X; Xiao N; Dong J; Wang D
    J Infect Chemother; 2018 Sep; 24(9):729-733. PubMed ID: 29866491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.